Allergies
Perrigo Settles Desloratadine Patent Litigation
Published in Physician Law Weekly, December 17th, 2008
The Perrigo Company (NASDAQ:PRGO) announced that all Hatch-Waxman litigation relating to Desloratadine tablets (5 mg) has been settled with Perrigo taking a license under all relevant patents. Perrigo had been sued for patent infringement of US Patent Nos. 6100274, 7214683 and 7214684 based upon its filing of an ANDA containing a Paragraph IV certification. Under the terms of the settlement, Perrigo can commercially launch its generic Desloratadine product on July 1, 2012, or earlier in certain circumstances. The new product launch may be a prescription or over-the-counter (OTC) product depending on its status at the time of launch. The Perrigo product is awaiting FDA approval.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2008-12-17)
More Articles from Physician Law Weekly
- AARP
AARP Tax-Aide Seeks Bilingual Volunteers for 2009 - Abitibibowater INC. - English
AbitibiBowater and Starcom Enter into Exclusive Sales Agreement - Acuo Technologies
Acuo Technologies Announces Vendor Neutral Archiving Contract With Children's Hospital of Philadelphia - Addiction Medicine
Researchers from Indiana University describe findings in addiction medicine - Addiction Medicine
Studies in the area of addiction medicine reported from S.M. Rosen and co-researchers - Alcoholism
Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
